Table 2 An analysis of the demographic characteristics of participants in the MenSC therapy and control groups at the onset of the study
Parameters | In ≤ 40years old group | In > 40years old group | ||||
|---|---|---|---|---|---|---|
MenSC group (n = 44) | Control group (n = 44) | P-value | MenSC group (n = 44) | Control group (n = 41) | P-value | |
Age (years) | 34.9 ± 3.6 | 34.3 ± 3.4 | NS | 42.7 ± 1.8 | 42.2 ± 1 | NS |
duration of infertility (years) | 4.8 ± 4 | 4.9 ± 4.3 | NS | 25.5 ± 4.8 | 25 ± 3.5 | NS |
Gravid number | 0.5 ± 0.8 | 0.3 ± 0.5 | NS | 0.5 ± 0.6 | 0.6 ± 0.8 | NS |
BMI | 24.9 ± 3.7 | 24.9 ± 4 | NS | 25.5 ± 4.8 | 25 ± 3.5 | NS |
Sperm count (mill/ml) | 35.5 ± 14.5 | 33 ± 12.4 | NS | 29.1 ± 13.4 | 31.8 ± 16.9 | NS |
No. of oocytes | 1.4 ± 1.4 | 1.9 ± 1.3 | NS | 0.8 ± 1.3 | 1.2 ± 1.2 | NS |
No. of MII oocytes | 0.8 ± 1.1 | 1.2 ± 1.1 | NS | 0.4 ± 0.7 | 0.5 ± 0.9 | NS |
No. of embryos | 0.7 ± 1.1 | 1 ± 1 | NS | 0.4 ± 0.7 | 0.7 ± 0.7 | NS |
No. of High-quality embryos | 0.3 ± 0.7 | 0.4 ± 0.5 | NS | 0.09 ± 0.29 | 0.15 ± 0.3 | NS |
AMH (ng/mL) | 0.4 ± 0.4 | 0.5 ± 0.4 | NS | 0.3 ± 0.3 | 0.4 ± 0.3 | NS |
FSH (IU/L) | 12.8 ± 7.4 | 11 ± 4.3 | NS | 16.7 ± 11.4 | 12.9 ± 5.8 | NS |
AFC | 2 ± 1.8 | 2.6 ± 1.5 | NS | 2.0 ± 1.4 | 2.2 ± 1.0 | NS |